Trial Profile
Phase II Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2020
Price :
$35
*
At a glance
- Drugs Bosentan (Primary) ; Budesonide/formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Apr 2014 New trial record